Author:
Gnanasegaran Gopinath,Kissoor Shaunak Naval,Agrawal Kanhaiya
Reference36 articles.
1. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC;Artiko;Journal of BUON,2012
2. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide;Bangard;European Journal of Nuclear Medicine,2000
3. Peptide receptor targeting in cancer: the somatostatin paradigm;Barbieri;International Journal of Peptide,2013
4. Characterisation of 99mTc EDDA/HYNIC-TOC (Tektrotyd) physiological and neuroendocrine tumour uptake using SPECT/CT standardised uptake values: Initial experience;Caitlin;Nuclear Medicine Communications,2021
5. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer;Chen;European Journal of Nuclear Medicine and Molecular Imaging,2020